טוען...
Eltrombopag-related renal vein thromboembolism in a patient with immune thrombocytopenia: A case report
BACKGROUND: Eltrombopag is an orally administered thrombopoietin receptor agonist linked to a heightened risk of treatment-related thromboembolism. Both venous and arterial thromboses have been documented in the medical literature. CASE SUMMARY: In the absence of nephropathy, a 48-year-old patient r...
שמור ב:
| הוצא לאור ב: | World J Clin Cases |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Baishideng Publishing Group Inc
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8040189/ https://ncbi.nlm.nih.gov/pubmed/33889627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v9.i11.2611 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|